After news of a Florida man being cured of coronavirus thanks to chloroquine, the drug is now being fast-tracked as a potential solution to the global pandemic.
Of course, the federal government is funneling billions upon billions of dollars into stemming the outbreak…
Which means that the company that ends up with the federal contract to manufacture a COVID-19 cure stands to see a windfall of epic proportions.
Now the drug has not yet been officially approved for treatment of the disease…
But trials are ramping up, and rumors are circulating that the White House has already tapped a firm to increase production and prepare for nationwide distribution.
So how can you identify which company is likely to get the deal?
Simple: follow the money.
I mean, just think about it…
What would you do if you knew your company was about to be handed the biggest production contract in its history?
… If you were expecting record profits and a huge surge in sales?
If you’re anything like me, you’d probably buy stock in your company.
A LOT of it.
Well, I’ve done the research…
And there’s only one pharmaceutical company with the capacity to produce this drug on a large enough scale that insiders are buying in big size…
Click here to learn how to become a member and get your hands on this ticker RIGHT NOW!